CervoMed Stock (NASDAQ: CRVO) stock price, news, charts, stock research, profile.
You can purchase shares of CervoMed (NASDAQ:CRVO) through any online brokerage.
Other companies in CervoMed’s space includes: Renovaro (NASDAQ:RENB), CytomX Therapeutics (NASDAQ:CTMX), Aligos Therapeutics (NASDAQ:ALGS), Armata Pharmaceuticals (AMEX:ARMP) and Citius Oncology (NASDAQ:CTOR).
CervoMed has a consensus price target of $53.67.
The stock price for CervoMed (NASDAQ: CRVO) is $10.05 last updated November 22, 2024 at 8:39 AM EST.
There are no upcoming dividends for CervoMed.
CervoMed’s Q3 earnings are confirmed for Tuesday, November 12, 2024.
There is no upcoming split for CervoMed.
CervoMed is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.